Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 4/20 | 0.38 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.38 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.38 |
| ▸ | GRIK1 | P39086 | 4/20 | 0.37 |
| ▸ | GRIK2 | Q13002 | 3/20 | 0.37 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.36 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | HRH1 | P35367 | 1/20 | 0.36 |
| ▸ | DRD3 | P35462 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28592775 | 0.84 | GRIK1 (0.47) | ALDH1A1MAPTPTGS1SLC1A2SLC1A1 | |
| SCHEMBL28580757 | 0.84 | GRIK1 (0.47) | ALDH1A1MAPTPTGS1SLC1A2SLC1A1 | |
| SCHEMBL28586954 | 0.84 | GRIK1 (0.47) | ALDH1A1MAPTPTGS1SLC1A2SLC1A1 | |
| SCHEMBL23099396 | 0.82 | ALDH1A1 (0.48) | ALDH1A1MAPTPTGS1LMNAGRIK1 | |
| SCHEMBL26982392 | 0.82 | ALDH1A1 (0.48) | ALDH1A1MAPTPTGS1LMNAGRIK1 | |
| SCHEMBL3821550 | 0.81 | ALDH1A1 (0.52) | ALDH1A1MAPTPTGS1SLC1A2SLC1A1 | |
| SCHEMBL1631413 | 0.81 | ALDH1A1 (0.52) | ALDH1A1MAPTPTGS1SLC1A2SLC1A1 | |
| SCHEMBL12655754 | 0.80 | ALDH1A1 (0.46) | ALDH1A1MAPTPTGS1SLC1A2SLC1A1 | |
| Hydrochloric Acid SCHEMBL7379812 | 0.79 | ALDH1A1 (0.50) | ALDH1A1MAPTPTGS1SLC1A2SLC1A1 | |
| Hydrochloric Acid SCHEMBL23462497 | 0.79 | ALDH1A1 (0.50) | ALDH1A1MAPTPTGS1SLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0626941-A1 | PROCESS FOR THE PREPARATION OF $g(b),$g(b)-DIALKYL AND $g(b),$g(b),$g(b)-TRIALKYL $g(a)-AMINO ACIDS | THE ASSOCIATED OCTEL COMPANY LIMITED (GB) | 1994-12-07 | — | — | EP | claimed |
| WO-1993016032-A1 | PROCESS FOR THE PREPARATION OF β,β-DIALKYL AND β,β,β-TRIALKYL α-AMINO ACIDS | THE ASSOCIATED OCTEL COMPANY LIMITED (GB) | 1993-08-19 | — | — | WO | claimed |
| US-20230053449-A1 | DC-SIGN ANTIBODY DRUG CONJUGATES | NOVARTIS AG (CH) | 2023-02-23 | — | — | US | disclosed |
| EP-0626941-A1 | PROCESS FOR THE PREPARATION OF $g(b),$g(b)-DIALKYL AND $g(b),$g(b),$g(b)-TRIALKYL $g(a)-AMINO ACIDS | THE ASSOCIATED OCTEL COMPANY LIMITED (GB) | 1994-12-07 | — | — | EP | disclosed |
| WO-1993016032-A1 | PROCESS FOR THE PREPARATION OF β,β-DIALKYL AND β,β,β-TRIALKYL α-AMINO ACIDS | THE ASSOCIATED OCTEL COMPANY LIMITED (GB) | 1993-08-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230053449-A1 | DC-SIGN ANTIBODY DRUG CONJUGATES | DCUN1D4, CD14, DCUN1D3 | ALDH1A1 2550/4885MAPT 1439/4885PTGS1 4363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.